NCT00716976 · OUTCOME

Change in Hearing Thresholds For Key Frequencies at 1000 hz

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy · Source last updated 2023-11-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: Decibels
Interval / dispersion: Standard Deviation
Time frame: 4 weeks after last dose of cisplatin

What was measured

Mean change in hearing threshold (post-pre) at 1000 hz.

Analysis population: 37 eligible patients in the STS arm had paired audiometry at 1000 hz; 47 patients in the observation arm had paired audiometry at 1000 hz.

Groups in this outcome

STS Arm (Sodium Thiosulfate Treatment)

Sodium thiosulfate treatment.

Observation Arm

No sodium thiosulfate treatment.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
STS Arm (Sodium Thiosulfate Treatment)	37
Observation Arm	47

Reported measurements

Source class 1

Values in Decibels · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
STS Arm (Sodium Thiosulfate Treatment)	-0.676	4.59	Not reported	Not reported	Not reported
Observation Arm	-0.319	8.99	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
4.59
value
-0.676
group Id
OG001
spread
8.99
value
-0.319

denoms

counts
group Id
OG000
value
37
group Id
OG001
value
47
units
Participants

description

Mean change in hearing threshold (post-pre) at 1000 hz.

dispersion Type

Standard Deviation

groups

description
Sodium thiosulfate treatment.
id
OG000
title
STS Arm (Sodium Thiosulfate Treatment)
description
No sodium thiosulfate treatment.
id
OG001
title
Observation Arm

param Type

MEAN

population Description

37 eligible patients in the STS arm had paired audiometry at 1000 hz; 47 patients in the observation arm had paired audiometry at 1000 hz.

reporting Status

POSTED

time Frame

4 weeks after last dose of cisplatin

title

Change in Hearing Thresholds For Key Frequencies at 1000 hz

type

SECONDARY

unit Of Measure

Decibels

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice